Maryland Capital Advisors’s Merck MRK Stock Holding History

Maryland Capital Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$331K	Buy	+2,577	New	+$302K	0.11%	67
2025 Q4	$292K	Sell	2,777 -43	-2%	-$4.04K	0.1%	73
2025 Q3	$237K	Hold	2,820	–	–	0.08%	78
2025 Q2	$223K	Hold	2,820	–	–	0.09%	75
2025 Q1	$253K	Hold	2,820	–	–	0.11%	67
2024 Q4	$281K	Hold	2,820	–	–	0.13%	65
2024 Q3	$320K	Hold	2,820	–	–	0.16%	59
2024 Q2	$349K	Hold	2,820	–	–	0.19%	51
2024 Q1	$372K	Hold	2,820	–	–	0.23%	49
2023 Q4	$307K	Hold	2,820	–	–	0.2%	51
2023 Q3	$290K	Sell	2,820 -73	-3%	-$7.87K	0.22%	53
2023 Q2	$334K	Hold	2,893	–	–	0.27%	48
2023 Q1	$308K	Hold	2,893	–	–	0.27%	50
2022 Q4	$321K	Hold	2,893	–	–	0.3%	47
2022 Q3	$249K	Hold	2,893	–	–	0.26%	47
2022 Q2	$264K	Sell	2,893 -37	-1%	-$3.28K	0.28%	45
2022 Q1	$240K	Sell	2,930 -138	-4%	-$10.9K	0.21%	47
2021 Q4	$235K	Buy	+3,068	New	+$244K	0.19%	49

Other funds holding MRK

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Maryland Capital Advisors's MRK Position: Q2 2026 in Review

Maryland Capital Advisors opened a new position in Merck (MRK) in Q2 2026: 2,577 shares worth $331K. The stake represents 0.11% of the portfolio and ranks #67 among its holdings. This is a return to the name: Maryland Capital Advisors previously reported a position in MRK as recently as Q4 2025.

Maryland Capital Advisors first reported a position in MRK in Q4 2021 and has held it in 18 quarters since. The position peaked at $372K in Q1 2024. 2,132 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Maryland Capital Advisors held 2,577 shares of Merck worth $331K as of Q2 2026.
Merck was a new Maryland Capital Advisors position in Q2 2026.
Merck made up 0.11% of Maryland Capital Advisors's portfolio in Q2 2026, its #67 holding.
Maryland Capital Advisors first reported a position in Merck in Q4 2021 and has held it in 18 quarters since.
Maryland Capital Advisors's Merck position peaked at $372K in Q1 2024.
2,132 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Maryland Capital Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.